Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control
Publication
, Conference
Gondar, RK; Hjelmeland, MD; Keir, ST; Conrad, CA; McLendon, RE; Wikstrand, CJ; Traxler, P; Lane, HA; Reardon, DA; Cavenee, WK; Wang, XF ...
Published in: NEURO-ONCOLOGY
October 1, 2004
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
407 / 407
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gondar, R. K., Hjelmeland, M. D., Keir, S. T., Conrad, C. A., McLendon, R. E., Wikstrand, C. J., … Rich, J. N. (2004). Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control. In NEURO-ONCOLOGY (Vol. 6, pp. 407–407). Boston, MA: DUKE UNIV PRESS.
Gondar, R. K., M. D. Hjelmeland, S. T. Keir, C. A. Conrad, R. E. McLendon, C. J. Wikstrand, P. Traxler, et al. “Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control.” In NEURO-ONCOLOGY, 6:407–407. DUKE UNIV PRESS, 2004.
Gondar RK, Hjelmeland MD, Keir ST, Conrad CA, McLendon RE, Wikstrand CJ, et al. Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 407–407.
Gondar, R. K., et al. “Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 407–407.
Gondar RK, Hjelmeland MD, Keir ST, Conrad CA, McLendon RE, Wikstrand CJ, Traxler P, Lane HA, Reardon DA, Cavenee WK, Wang XF, Bigner DD, Friedman HS, Rich JN. Inhibition of receptor tyrosine kinases and mammalian target of rapamycin offers combinatorial benefit in tumor control. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 407–407.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
407 / 407
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences